Taking daily medication can be a challenge for many, leading to increased viral load over time. Injectable therapies remove that challenge.

UCSF oncology scientist Paddy O'Leary won the 112th running of the Dipsea Race, the country's oldest trail race, on June 11. We caught up with him to learn more about his running, work and what drives him.

A rare burst of visual creativity is seen occasionally in patients with frontotemporal dementia. A UCSF-led study offers new insights into how this talent develops as key areas of the brain degenerate.

Janhavi Bonville, UCSF Associate Executive Vice Chancellor and Provost, shares her story and experience in working at UCSF with a physical disability and the importance of eliminating stigmas against people with disabilities.

UCSF doctors are leading a national movement to protect patients and the environment from anesthesia-related pollution.

Improving predictive models with artificial intelligence may help advance diagnostics for heart disease and limit invasive testing with catheters that can be risky, especially for patients already experiencing heart and stroke issues.

UCSF researchers are working across disease specialties. Diabetes researchers are looking at how oncologists use CAR T-cell therapy to reprogram a person’s immune system to attack cancer cells, for example. They hope to similarly reprogram the immune system to fight diabetes.